Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Pressmeddelande Hoersholm, Danmark och Cambridge, MA, US, 22 mars 2019 – Oncology Venture A/S meddelar idag att observationsstatusen för aktien på Nasdaq First North har tagits bort. Beslutet...
-
Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that the observation status for the share on Nasdaq First North has been removed. The...
-
ROME, March 22, 2019 (GLOBE NEWSWIRE) -- During President Xi Jinping’s state visit to Italy, Jane Sun, CEO of Ctrip International and Luigi Fiorentino, Head of Cabinet of the Minister of Tourism,...
-
COLUMBIA, Md., March 22, 2019 (GLOBE NEWSWIRE) -- Tenable®, Inc., the Cyber Exposure company, has been named a March 2019 Gartner Peer Insights Customers’ Choice for Vulnerability Assessment (VA)....
-
SALT LAKE CITY, March 22, 2019 (GLOBE NEWSWIRE) -- Capital Financial Global, Inc. (OTC Pink: CFGX), announced today that it has successfully completed a merger with Affiliated Funding Corporation...
-
DALLAS, March 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Puration Inc. (USOTC: PURA) (“PURA”) today published an update on the...
-
DALLAS, March 22, 2019 (GLOBE NEWSWIRE) -- Transwestern Investment Group (TIG®) today announces it has sold a 3.5 million-square-foot industrial portfolio on behalf of one of its discretionary...
-
CORPUS CHRISTI, TEXAS, March 22, 2019 (GLOBE NEWSWIRE) -- Transwestern Commercial Services (TCS) today announces it has been retained by David Z. Mafrige Interests (DZMI) to provide leasing services...
-
BBS-Bioactive Bone Substitutes Plc Correction to Financial Statement Bulletin of BBS-Bioactive Bone Substitutes Plc, published 22th March 2019 at 9:00 CET. Unfortunately, some incorrect dates and...
-
LONDON, March 22, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing...